
CVS Health split: Aetna and drugstores to part by 2028
CVS Health (CVS) plans to separate its drugstore chain from Aetna and Caremark into two public companies by early 2028, and shares rose after hours.
Daily Digest
Daily Digest
Company hub
Everything Pomegra has published on UNH: 16 news articles and 5 market briefs, newest first.
CVS Health (CVS) would spin off 9,000 drugstores by 2028, undoing its $78B Aetna deal amid political pressure.
Nov 4
Elevance Health (ELV) lifted its 2026 profit floor to at least $29 a share as medical costs fell.
Oct 22
UnitedHealth (UNH) now expects at least $20.50 in 2026 profit per share as medical costs and Optum improve
Oct 20
UnitedHealth (UNH) lifted its 2026 profit forecast to at least $20.50 a share as Optum margins improved.
Oct 13
Humana (HUM) now has 95% of Medicare Advantage members in 4-star plans, up from 20%, and Baird upgraded it.
Oct 9

CVS Health (CVS) plans to separate its drugstore chain from Aetna and Caremark into two public companies by early 2028, and shares rose after hours.

UnitedHealth (UNH) beat Q3 2026 earnings with $4.69 adjusted EPS and raised its full-year outlook to at least $20.50 per share, its third increase this year.

US earnings season opens with JPMorgan, Wells Fargo and UnitedHealth, with profit growth near 30% expected and a 7% options-implied move in UNH stock.
UnitedHealth (UNH) reports Q3 2026 earnings on Oct. 13, with Medicare Advantage margins in focus after Humana's 11.6% surge on 2027 Medicare star ratings.
Humana shares surged about 15% after its largest Medicare Advantage contract rose to 4 stars, while Alignment Healthcare fell more than 20% on a downgrade.

Democratic polling gains trigger a sector shift into healthcare and utilities while defense and energy sell off on a volatile triple-witching Friday.

US equity futures moved cautiously higher on Thursday, July 16, as renewed Iran ceasefire diplomacy and a cooling inflation reading offset chip-sector turbulence sparked by TSMC's post-earnings…

The Dow Jones Industrial Average closed H1 2026 up 8.9%, its strongest first-half performance since 2021, driven by record earnings, tariff relief, and an AI-fueled semiconductor surge.

Moderna shares surged 48% in June as an FDA flu vaccine endorsement and sector rotation away from semiconductors lifted healthcare and biotech stocks broadly.

Verizon, AT&T, and Cigna have filed fresh WARN Act notices in 2026, signaling that telecom and insurance sectors are accelerating workforce cuts as AI automation and surging medical costs rewrite…

Wall Street strategists warn a massive market rotation may be underway as AI-driven tech stocks mirror the narrow concentration patterns last seen in 2020's pandemic-era surge.

Berkshire Hathaway's first 13F under CEO Greg Abel reveals a sweeping portfolio cleanup — 16 full exits including dividend stalwart Pool Corp, as capital rotates toward concentrated,…

Investors are closely monitoring the Berkshire Hathaway transition as Greg Abel steps into the CEO role and Warren Buffett reshapes his legacy from the chairman's seat.

UnitedHealth Group shares reclaimed the critical $300 level on April 7, 2026, fueled by a landmark Medicare Advantage payment increase from federal regulators and a fresh analyst upgrade. The twin cat...

UnitedHealth Group continued its downward trajectory in Monday's trading session, with shares declining 1.3% to close at $351.64 as investors braced for the company's fourth-quarter earnings…

UnitedHealth Group delivered better-than-expected fourth quarter results on January 27, demonstrating resilience amid persistent medical cost inflation that has pressured the healthcare sector…